statistics

Incorrectly analysing stratified and minimised trials may lead to wrongfully rejecting superiority of interventions
Reinier Cornelis Anthonius van Linschoten, Rachel West, Desirée van Noord, Nikki van Leeuwen

Gut May 2022, 71 (5) 1038-1039; DOI: 10.1136/gutjnl-2021-324936
Biopsy and blood-based molecular biomarker of inflammation in IBD
Carmen Argmann, Ruixue Hou, Ryan C Ungaro, Haritz Irizar, Zainab Al-Taie, Ruiqi Huang, Roman Kosoy, Swati Venkat, Won-Min Song, Antonio F Di'Narzo, Bojan Losic, Ke Hao, Lauren Peters, Phillip H Comella, Gabrielle Wei, Ashish Atreja, Milind Mahajan, Alina Iuga, Prerak T Desai, Patrick Branigan, Aleksandar Stojmirovic, Jacqueline Perrigoue, Carrie Brodmerkel, Mark Curran, Joshua R Friedman, Amy Hart, Esi Lamousé-Smith, Jan Wehkamp, Saurabh Mehandru, Eric E Schadt, Bruce E Sands, Marla C Dubinsky, Jean-Frederic Colombel, Andrew Kasarskis, Mayte Suárez-Fariñas

Gut Jul 2023, 72 (7) 1271-1287; DOI: 10.1136/gutjnl-2021-326451
Pancreatic cancer risk and levels of trace elements
André F S Amaral, Miquel Porta, Debra T Silverman, Roger L Milne, Manolis Kogevinas, Nathaniel Rothman, Kenneth P Cantor, Brian P Jackson, José A Pumarega, Tomàs López, Alfredo Carrato, Luisa Guarner, Francisco X Real, Núria Malats

Gut Nov 2012, 61 (11) 1583-1588; DOI: 10.1136/gutjnl-2011-301086
Dietary antioxidants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers
Paul J R Banim, Robert Luben, Alison McTaggart, Ailsa Welch, Nicholas Wareham, Kay-Tee Khaw, Andrew R Hart

Gut Oct 2013, 62 (10) 1489-1496; DOI: 10.1136/gutjnl-2011-301908
Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates
Chelsie K Sievers, Luli S Zou, Perry J Pickhardt, Kristina A Matkowskyj, Dawn M Albrecht, Linda Clipson, Jeffery W Bacher, B Dustin Pooler, Fouad J Moawad, Brooks D Cash, Mark Reichelderfer, Tien N Vo, Michael A Newton, Bret R Larget, Richard B Halberg

Gut Dec 2017, 66 (12) 2132-2140; DOI: 10.1136/gutjnl-2016-312232
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber, Bruce E Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter D R Higgins, Jan Wehkamp, Brian G Feagan, Michael D Yao, Marek Karczewski, Jacek Karczewski, Nicole Pezous, Stephan Bek, Gerard Bruin, Bjoern Mellgard, Claudia Berger, Marco Londei, Arthur P Bertolino, Gervais Tougas, Simon P L Travis, for the Secukinumab in Crohn's Disease Study Group

Gut Dec 2012, 61 (12) 1693-1700; DOI: 10.1136/gutjnl-2011-301668
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
Yi-Chia Lee, Tony Hsiu-Hsi Chen, Han-Mo Chiu, Chia-Tung Shun, Hung Chiang, Tzeng-Ying Liu, Ming-Shiang Wu, Jaw-Town Lin

Gut May 2013, 62 (5) 676-682; DOI: 10.1136/gutjnl-2012-302240
Reliability and agreement studies: a guide for clinical investigators
Ruben Hernaez

Gut Jul 2015, 64 (7) 1018-1027; DOI: 10.1136/gutjnl-2014-308619
Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
Jochen Metzger, Ahmed A Negm, Ruben R Plentz, Tobias J Weismüller, Jochen Wedemeyer, Tom H Karlsen, Mohammed Dakna, William Mullen, Harald Mischak, Michael P Manns, Tim O Lankisch

Gut Jan 2013, 62 (1) 122-130; DOI: 10.1136/gutjnl-2012-302047

Log in using your username and password

Main menu

Log in using your username and password

You are here

statistics